Palvella Therapeutics (PVLA) Other Gross PP&E Adjustments: 2013-2023
Historic Other Gross PP&E Adjustments for Palvella Therapeutics (PVLA) over the last 6 years, with Dec 2023 value amounting to -$960,000.
- Palvella Therapeutics' Other Gross PP&E Adjustments fell 104.19% to -$960,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $67.7 million, marking a year-over-year decrease of 23.90%. This contributed to the annual value of -$960,000 for FY2023, which is 104.19% down from last year.
- As of Q4 2023, Palvella Therapeutics' Other Gross PP&E Adjustments stood at -$960,000, which was down 104.20% from $22.9 million recorded in Q2 2023.
- In the past 5 years, Palvella Therapeutics' Other Gross PP&E Adjustments ranged from a high of $23.9 million in Q4 2020 and a low of -$960,000 during Q4 2023.
- Over the past 3 years, Palvella Therapeutics' median Other Gross PP&E Adjustments value was $22.9 million (recorded in 2021), while the average stood at $20.5 million.
- In the last 5 years, Palvella Therapeutics' Other Gross PP&E Adjustments skyrocketed by 155.14% in 2020 and then plummeted by 104.19% in 2023.
- Over the past 5 years, Palvella Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $19.6 million in 2019, then climbed by 21.87% to $23.9 million in 2020, then dropped by 4.17% to $22.9 million in 2021, then grew by 0.02% to $22.9 million in 2022, then crashed by 104.19% to -$960,000 in 2023.
- Its Other Gross PP&E Adjustments was -$960,000 in Q4 2023, compared to $22.9 million in Q2 2023 and $22.9 million in Q1 2023.